SCHEMBL25536017

SCHEMBL25536017

CC1(C)c2ccccc2-c2ccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5ccc6c(c5)C(C)(c5ccccc5)c5ccccc5-6)c5ccccc45)n3)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 12/20 0.35
KMT2A Q03164 12/20 0.35
ALDH1A1 P00352 8/20 0.35
HPGD P15428 7/20 0.35
MAPT P10636 7/20 0.35
KDM4E B2RXH2 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
ACACA Q13085 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NTSR1 P30989 1/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33
PDK2 Q15119 2/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25535990 0.94 MEN1 (0.38) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25538833 0.94 CYP1A1 (0.34) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25536001 0.93 MEN1 (0.38) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25539364 0.93 CYP1A1 (0.32) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25535763 0.92 MEN1 (0.35) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25533729 0.92 MEN1 (0.39) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25539367 0.92 CYP1A1 (0.33) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25536006 0.91 PDK2 (0.37) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25533710 0.91 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25533706 0.89 PDK2 (0.40) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885ALDH1A1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.